Annual report pursuant to Section 13 and 15(d)

Mortgage Note Receivable

v3.10.0.1
Mortgage Note Receivable
12 Months Ended
Dec. 31, 2018
Debt Disclosure [Abstract]  
Mortgage Note Receivable
Mortgage Note Receivable

On July 25, 2014, we closed a $5.6 million second mortgage development loan for the construction of an 81,371 square foot, build-to-suit transitional care facility located on a major hospital campus in Phoenix, Arizona. Subsequently, on April 14, 2015, we closed an additional $0.3 million interim financing loan for the development of the Phoenix, Arizona property. Construction was completed in July 2015 and we earned 9.0% interest, paid currently in cash, on the loan during construction and through maturity. Prior to completion of the facility, we were granted a right of first offer to purchase the property at fair value. We elected not to purchase the property, but did receive an exit fee upon maturity of the loan in an amount sufficient for us to earn an internal rate of return of 22.0% on the second mortgage development loan, inclusive of interest earned. We have recognized $0.0 million, $0.0 million and $0.4 million in aggregate cash interest income and accrued exit fee revenue during the years ended December 31, 2018, 2017, and 2016, respectively. The principal balance of the loans and all associated interest and exit fee revenue was received in January 2016. We currently have no mortgage notes receivable outstanding.